Mavens Biotech standalone net profit declines 78.57% in the September 2014 quarter
Reported sales nil
Net profit of Mavens Biotech declined 78.57% to Rs 0.03 crore in the quarter ended September 2014 as against Rs 0.14 crore during the previous quarter ended September 2013. There were no Sales reported in the quarter ended September 2014 as against Rs 10.43 crore during the previous quarter ended September 2013. ParticularsQuarter EndedSep. 2014Sep. 2013% Var.Sales010.43 -100 OPM %01.53 -PBDT0.070.19 -63 PBT0.030.14 -79 NP0.030.14 -79Powered by Capital Market - Live News